AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Sitalong M Tablet PR

Prescription Icon
Prescription Required

Marketer

Alteus Biogenics Pvt Ltd

Salt Composition

Sitagliptin (100mg) + Metformin (1000mg)

Overview Sitalong M Tablet PR

Combiflex DM tablets combine two medications to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, and may lessen the risk of cardiovascular events. Combiflex DM may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, blood glucose readings, and other concurrent medications. Taking it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under physician guidance. Adherence to your prescribed diet and exercise plan is crucial for diabetes control; lifestyle significantly impacts management. Common side effects include diarrhea, nausea, vomiting, dyspepsia, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, especially when combined with insulin or sulfonylureas; learn to identify and manage this condition. This medication isn't suitable for all individuals. Inform your physician of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption before starting treatment. Pregnant or lactating women require medical consultation prior to use. Potential drug interactions exist; disclose all medications to your doctor to ensure safety. Alcohol should be minimized due to its hypoglycemic effects. Your doctor will monitor renal function and blood glucose levels throughout treatment.

Uses of Sitalong M Tablet PR

Managing type 2 diabetes

Major Benefits of Sitalong M Tablet PR:

Follow your physician's instructions or consult the product labeling for usage guidelines. Administer Sitalong M Tablet PR with meals.

Common Side effects of Sitalong M Tablet PR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitalong M Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidance. Administer Sitalong M Tablet PR with a meal.

How Sitalong M Tablet PR works:

Sitalong M Tablet PR combines sitagliptin and metformin to effectively manage blood glucose levels. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and lessens hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitalong M Tablet PR and alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Sitalong M Tablet PR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Breastfeeding mothers should likely avoid Sitalong M Tablet PR. Available evidence indicates potential drug transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Sitalong M Tablet PR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Sitalong M Tablet PR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver conditions should likely refrain from using Sitalong M Tablet PR due to potential safety concerns. A physician's consultation is recommended.

What if you forget to take Sitalong M Tablet PR :

Should you forget a Sitalong M Tablet PR dose, administer it promptly. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitalong M Tablet PR

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Sitalong M Tablet PR

Sitalong M Tablet PR combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This medication helps regulate blood sugar when used alongside a healthy diet and physical activity. Metformin reduces liver glucose production and enhances insulin sensitivity. Sitagliptin blocks DPP4, boosting insulin secretion from the pancreas. This formulation is unsuitable for individuals under 18.
Prolonged Sitalong M Tablet PR administration can indeed lead to vitamin B12 deficiency. This medication disrupts the body's ability to absorb vitamin B12 from the gastrointestinal tract. Untreated deficiency can result in anemia and neurological complications, potentially manifesting as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental vitamin B12 intake, at a minimum of once annually, is recommended by some experts.
Sitalong M Tablet PR administration may result in frequent side effects such as low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially severe adverse reactions include lactic acidosis. Prolonged use might additionally cause vitamin B12 deficiency.
Patients with hypersensitivity to any Sitalong M Tablet PR ingredient or inactive substance should not use this medication. Similarly, its use is contraindicated in individuals with severely compromised renal or hepatic function, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalong M Tablet PR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Retain this medication in its original, tightly sealed container or packaging. Follow the storage guidelines printed on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Sitalong M Tablet PR use can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is a rare complication of metformin, prompting avoidance in individuals with kidney impairment, advanced age, or significant alcohol consumption. Symptoms might encompass muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Sitalong M Tablet PR combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when coupled with a healthy diet and regular physical activity. Metformin reduces hepatic glucose production and improves insulin responsiveness. Sitagliptin's mechanism involves DPP4 enzyme inhibition, thereby boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitalong M Tablet PR may cause common adverse reactions including low blood sugar (hypoglycemia), altered taste perception, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially severe side effects such as lactic acidosis may occur. Prolonged use might result in vitamin B12 deficiency.
Patients with hypersensitivity to any constituent or inactive ingredient of Sitalong M Tablet PR should not use this medication. Its administration is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive cardiac failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalong M Tablet PR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Indeed, Sitagliptin/Metformin tablets can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this rare adverse effect necessitates caution in patients with pre-existing kidney impairment, the elderly, or those consuming substantial alcohol. Symptoms such as muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia may indicate its onset. Should these symptoms appear, discontinue Sitagliptin/Metformin immediately and seek urgent medical attention.
Prolonged Sitalong M Tablet PR use can indeed lead to vitamin B12 deficiency by disrupting its gastrointestinal absorption. This deficiency, if left unaddressed, may result in anemia and neurological complications, manifesting as numbness and tingling in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental vitamin B12 is recommended annually by some experts.
Retain this medication within its original, securely sealed container. Follow the storage guidelines specified on the packaging. Discard any leftover medication. Ensure it remains inaccessible to children, animals, and others.
Sitalong M Tablet PR combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when coupled with a healthy diet and exercise regimen. Metformin reduces hepatic glucose production and improves insulin responsiveness. Sitagliptin works by suppressing DPP4 enzyme activity, thereby boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitalong M Tablet PR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Patients exhibiting hypersensitivity to any Sitalong M Tablet PR ingredient or inactive component should not use this medication. Its use is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalong M Tablet PR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Indeed, Sitagliptin + Metformin tablets can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon adverse reaction linked to metformin use, prompting avoidance in individuals with pre-existing kidney impairment, advanced age, or significant alcohol consumption. Lactic acidosis symptoms may encompass muscular discomfort or weakness, vertigo, fatigue, peripheral coldness, respiratory distress, nausea, emesis, abdominal pain, or bradycardia. Should these symptoms arise, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitalong M Tablet PR administration can indeed lead to vitamin B12 deficiency by hindering its gastric absorption. This deficiency, if left unaddressed, may result in anemia and neurological complications, manifesting as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, supplemental vitamin B12 intake, at least annually, is recommended by some investigators.
Maintain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Sitalong M Tablet PR
194
MRP 225
13% off